Vanta Holdings Inc. (VNTXF)
| Market Cap | 4.31M -34.8% |
| Revenue (ttm) | 135.78K +70.9% |
| Net Income | -6.62M |
| EPS | -1.50 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,201 |
| Open | 0.6000 |
| Previous Close | n/a |
| Day's Range | 0.6000 - 0.6000 |
| 52-Week Range | 0.2100 - 1.8000 |
| Beta | -0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 20, 2026 |
About Vanta Holdings
Vanta Holdings Inc. develops, manufactures, and distributes beverages and nutraceutical products in Canada and the United States. It operates through the Channel Distribution and Direct Commerce segments. The company offers alkaline water, Blackwater, and natural health products direct-to-consumer and through the e-commerce platform. The company was formerly known as Forte Group Holdings Inc. and changed its name to Vanta Holdings Inc. in January 2026. Vanta Holdings Inc. was incorporated in 2017 and is based in Vancouver, Canada. [Read more]
Financial Performance
In 2025, Vanta Holdings's revenue was 215,528, an increase of 164.90% compared to the previous year's 81,361. Losses were -9.82 million, 27.1% more than in 2024.
Financial numbers in CAD Financial StatementsNews
Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives
VANCOUVER, BC / ACCESS Newswire / August 27, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused ...
Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
VANCOUVER, BC / ACCESS Newswire / August 21, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused ...
Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c
News Release Highlights: U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 5...
Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET
VANCOUVER, BC / ACCESS Newswire / July 21, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on...
Vanta to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 10:00 a.m. ET
News Release Highlights: Vanta has been invited to present at Maxim Group's "Health, Wellness & Longevity" Virtual Conference on July 22, 2026, providing the Company with an opportunity to engage inst...
Vanta Announces Exclusive Global Brand Partnership and Worldwide Distribution Agreement for PickelBall Pixels (PBX) Branded Products Powered by Vanta Blackwater Featuring Patented Fulvic Isolation Technology(TM)
News Release Highlights: Vanta enters into an exclusive Global Brand Partnership and Master Distribution Agreement with Animal Spirits Limited, doing business as PickelBall Pixels (PBX), establishing ...
Vanta Announces Receipt of Distillery Manufacturer Licence, Expanding Manufacturing and Commercialization Capabilities at its British Columbia Beverage Manufacturing Facility
News Release Highlights: Vanta has been issued a Distillery Manufacturer Licence from the British Columbia Liquor and Cannabis Regulation Branch (LCRB), authorizing commercial spirits manufacturing wi...
Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC0, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta ...
Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform
News Release Highlights: Vanta enters into strategic operating and infrastructure agreement supporting the planned launch of a U.S.-focused peptide therapy and longevity platform leveraging telehealth...
Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million
VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta pr...
Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta pr...